Thyroid Cancer | Tumor

CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.

LOXO-292 Granted Breakthrough Therapy Designation for Lung and Thyroid Cancer

September 5th 2018, 9:37pm

Article

The FDA has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with RET fusion–positive non–small cell lung cancer (NSCLC) or RET-mutant medullary thyroid cancer (MTC). This designation will expedite the development and review of the drug.

Searching for Understanding About RAS Mutations but Capitalizing on What We Know

August 16th 2018, 5:29pm

Article

From genetic mutations to treatment behind bars, here's a roundup of our 2018 Summer issue.

Saved by the TV Screen

August 9th 2018, 4:00pm

Podcast

In this week’s episode of CURE Talks Cancer, we spoke with Voigt about how he noticed a lump in a woman’s neck while watching tv and utilized the power of social media to find her – which ultimately led to a thyroid cancer diagnosis.

Stop, Look and Listen: Surveillance Is an Option for Thyroid Nodules

August 1st 2018, 11:37pm

Article

Instead of undergoing surgery for potential cancer, many people with thyroid nodules can safely opt for surveillance.

Managing Hypertension and Thyroid Cancer

July 18th 2018, 6:33pm

Video

High blood pressure is common in patients with thyroid cancer who are taking Lenvima. Here's what one expert says about managing it.

Facing Cancer Again

May 24th 2018, 5:23pm

Article

Cancer survivors worry about recurrence, but seldom think about their risk for new primaries.

FDA Approves Combination for Rare Thyroid Cancer Type

May 4th 2018, 9:07pm

Article

The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.

Training Through Treatments: Pro Runner Doesn't Let Cancer Slow Her Down

April 18th 2018, 8:54pm

Article

After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.

Tissue of Origin Test Results May Have Treatment Implications

April 16th 2018, 11:39pm

Article

Tests like these are growing increasingly important, as TOO results lead to treatment changes about 65 percent of the time and a site treatment change about 35 percent of the time, according to Cancer Genetics.

What Does it Mean to be a Cancer Survivor?

January 18th 2018, 10:13pm

Article